Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

NCT04359680 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1407

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
Viral Respiratory Illnesses

Interventions

DRUG: Nitazoxanide
DRUG: Placebo
DIETARY_SUPPLEMENT: Vitamin Super B-Complex

Sponsor

Romark Laboratories L.C.